We treated breast cancer cell lines with the well-known tamoxifen, which has already been FDA-approved for breast cancer treatment, and AG490, which is used as a JAK2 selective inhibitor, to compare the cytotoxicity of chalcone-9. This evidence concerns the gene JAK2 and breast cancer.